WallStSmart
QGEN

Qiagen NV

NYSE: QGEN · HEALTHCARE · DIAGNOSTICS & RESEARCH

$33.61
-1.21% today

Updated 2026-04-29

Market cap
$6.93B
P/E ratio
16.48
P/S ratio
3.31x
EPS (TTM)
$2.04
Dividend yield
0.77%
52W range
$33 – $58
Volume
1.9M

Qiagen NV (QGEN) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$101.48M$84.81M$173.00M$217.00M$250.75M$244.78M$244.88M$258.96M$287.96M$317.50M$341.60M$286.78M$359.50M$330.84M$492.27M$639.00M$715.26M$459.45M$673.55M$654.33M
Capital expenditures$35.35M$58.61M$57.92M$69.36M$123.91M$121.39M$128.09M$118.69M$97.00M$117.48M$93.92M$124.41M$150.76M$274.88M$304.24M$206.53M$149.34M$162.80M$167.17M$201.05M
Depreciation
Stock-based comp$326.00M$8.98B$9.79M$9.75M$13.59M$19.54M$25.36M$37.94M$42.19M$27.57M$28.29M$34.44M$40.11M$65.89M$40.94M$38.39M$49.51M$47.10M$43.63M$50.40M
Free cash flow$66.13M$26.20M$115.08M$147.64M$126.84M$123.39M$116.80M$140.26M$190.96M$200.02M$247.68M$162.37M$208.73M$55.96M$188.03M$432.47M$565.93M$296.65M$506.38M$453.28M
Investing cash flow
Financing cash flow
Dividends paid$400.00M$13000.00$785.87M$769.66M$567.28M$622.20M$25.36M$0.00$0.00$54.24M
Share repurchases
Debt repayment
Net change in cash